BiotechTube
Home/Glycomine/Geoffrey Hird
GH

Geoffrey Hird

Chief Technology Officer

Glycomine

Therapeutic Areas

Rare Genetic DiseasesCongenital Disorders of GlycosylationMetabolic Disorders

Glycomine Pipeline

DrugIndicationPhase
GLM101PMM2-CDG (CDG-Ia)Phase 2b

Leadership Team at Glycomine

SA
Steven Axon
Chief Executive Officer
HA
Hicham Alaoui
Chief Scientific Officer
RM
Rose Marino
Chief Medical Officer
PM
Peter McWilliams
Chief Business Officer
View full Glycomine profile